TrialClinical and translational science2022

A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence.

Scott A Mosley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.